---
schema_version: "secwatch.filing_event.v1"
accession: "0001127537-26-000035"
form_type: "8-K"
ticker: "LUNG"
cik: "0001127537"
company_name: "Pulmonx Corp"
filed_at: "2026-07-29T20:07:39+00:00"
generated_at: "2026-07-29T20:09:26.710321+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Pulmonx Q2 revenue $22.8M (-5% YoY); net loss narrows to $10.1M

## Summary
- Revenue $22.8M, down 5% YoY; U.S. $14.2M (-4%), international $8.6M (-6%; ex-China +12%).
- Record gross margin 78% (vs 72% YoY); operating expenses down 16% to $26.8M.
- Net loss $10.1M ($0.24/share) vs $15.2M loss; adjusted EBITDA loss $5.1M, down 39%.
- Cash $55.8M; FY2026 guidance: revenue $90-92M, gross margin ~76%, opex $109-111M.
- Management cites cost realignment and expects return to year-over-year revenue growth.

## SEC filing metadata
- accession: 0001127537-26-000035
- form_type: 8-K
- ticker: LUNG
- cik: 0001127537
- company_name: Pulmonx Corp
- filed_at: 2026-07-29T20:07:39+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000035/0001127537-26-000035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000035/lung-20260729.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001127537-26-000035
- JSON: https://secwatch.observer/filing/0001127537-26-000035.json
- Plain text: https://secwatch.observer/filing/0001127537-26-000035.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.